National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 504992

History of Changes from the VAERS Wayback Machine

First Appeared on 1/13/2014

VAERS ID: 504992
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-10-01
Entered:2013-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Amenorrhoea, Confusional state, Dizziness, Headache, Hyperacusis, Hypoaesthesia, Irritable bowel syndrome, Menorrhagia, Migraine, Nausea, Night sweats, Pain, Photophobia, Rash, Syncope, Vomiting, Body temperature fluctuation

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1309CAN013914

Write-up:Health Authority Report: this spontaneous report as received from a consumer or other non health professional refers to a 13 year old female patient. On an unknown date the patient was vaccinated with GARDASIL, 1 DF, intramuscular. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced amenorrhoea (hospitalization, medically significant and disability), vomiting (hospitalization, medically significant and disability), syncope (hospitalization, medically significant and disability), rash (hospitalization, medically significant and disability), photophobia (hospitalization, medically significant and disability), pain (hospitalization, medically significant and disability), night sweats (hospitalization, medically significant and disability), nausea (hospitalization, medically significant and disability), migraine (hospitalization, medically significant and disability), menorrhagia (hospitalization, medically significant and disability), irritable bowel syndrome, (hospitalization, medically significant and disability), hypoaesthesia (hospitalization, medically significant and disability), hyperacusis (hospitalization, medically significant and disability), headache (hospitalization, medically significant and disability), dizziness (hospitalization, medically significant and disability), confusional state (hospitalization, medically significant and disability) and body temperature fluctuation (hospitalization, medically significant and disability). The outcome of amenorrhoea, vomiting, syncope, rash, photophobia, pain, night sweats, nausea, migraine, menorrhagia, irritable bowel syndrome, hypoaesthesia, hyperacusis, headache, dizziness, confusional state and body temperature fluctuation was reported as not recovered/not resolved. It is unknown if these events are related to GARDASIL. Additional information is not expected.


Changed on 6/14/2014

VAERS ID: 504992 Before After
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-10-01
Entered:2013-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Amenorrhoea, Confusional state, Dizziness, Headache, Hyperacusis, Hypoaesthesia, Irritable bowel syndrome, Menorrhagia, Migraine, Nausea, Night sweats, Pain, Photophobia, Rash, Syncope, Vomiting, Body temperature fluctuation

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1309CAN013914

Write-up:Health Authority Report: this spontaneous report as received from a consumer or other non health professional refers to a 13 year old female patient. On an unknown date the patient was vaccinated with GARDASIL, 1 DF, intramuscular. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced amenorrhoea (hospitalization, medically significant and disability), vomiting (hospitalization, medically significant and disability), syncope (hospitalization, medically significant and disability), rash (hospitalization, medically significant and disability), photophobia (hospitalization, medically significant and disability), pain (hospitalization, medically significant and disability), night sweats (hospitalization, medically significant and disability), nausea (hospitalization, medically significant and disability), migraine (hospitalization, medically significant and disability), menorrhagia (hospitalization, medically significant and disability), irritable bowel syndrome, (hospitalization, medically significant and disability), hypoaesthesia (hospitalization, medically significant and disability), hyperacusis (hospitalization, medically significant and disability), headache (hospitalization, medically significant and disability), dizziness (hospitalization, medically significant and disability), confusional state (hospitalization, medically significant and disability) and body temperature fluctuation (hospitalization, medically significant and disability). The outcome of amenorrhoea, vomiting, syncope, rash, photophobia, pain, night sweats, nausea, migraine, menorrhagia, irritable bowel syndrome, hypoaesthesia, hyperacusis, headache, dizziness, confusional state and body temperature fluctuation was reported as not recovered/not resolved. It is unknown if these events are related to GARDASIL. Additional information is not expected.


Changed on 3/14/2015

VAERS ID: 504992 Before After
Age:13.0
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2013-10-01
Entered:2013-10-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Amenorrhoea, Confusional state, Dizziness, Headache, Hyperacusis, Hypoaesthesia, Irritable bowel syndrome, Menorrhagia, Migraine, Nausea, Night sweats, Pain, Photophobia, Rash, Syncope, Vomiting, Body temperature fluctuation

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Unknown
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1309CAN013914

Write-up:Health Authority Report: this spontaneous report as received from a consumer or other non health professional refers to a 13 year old female patient. On an unknown date the patient was vaccinated with GARDASIL, 1 DF, intramuscular. No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient experienced amenorrhoea (hospitalization, medically significant and disability), vomiting (hospitalization, medically significant and disability), syncope (hospitalization, medically significant and disability), rash (hospitalization, medically significant and disability), photophobia (hospitalization, medically significant and disability), pain (hospitalization, medically significant and disability), night sweats (hospitalization, medically significant and disability), nausea (hospitalization, medically significant and disability), migraine (hospitalization, medically significant and disability), menorrhagia (hospitalization, medically significant and disability), irritable bowel syndrome, (hospitalization, medically significant and disability), hypoaesthesia (hospitalization, medically significant and disability), hyperacusis (hospitalization, medically significant and disability), headache (hospitalization, medically significant and disability), dizziness (hospitalization, medically significant and disability), confusional state (hospitalization, medically significant and disability) and body temperature fluctuation (hospitalization, medically significant and disability). The outcome of amenorrhoea, vomiting, syncope, rash, photophobia, pain, night sweats, nausea, migraine, menorrhagia, irritable bowel syndrome, hypoaesthesia, hyperacusis, headache, dizziness, confusional state and body temperature fluctuation was reported as not recovered/not resolved. It is unknown if these events are related to GARDASIL. Additional information is not expected.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=504992&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166